Evidence map›Paper›PMID 40721674›Full record

ArticleNature neuroscience2025

Neural anticipation of virtual infection triggers an immune response.

Sara Trabanelli, Michel Akselrod, Julia Fellrath, Giulia Vanoni, Tommaso Bertoni, Silvia Serino, Georgia Papadopoulou, Maren Born, Matteo Girondini, Giuseppe Ercolano and 9 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Illusory cold desensitizes touch.bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sara Trabanelli *Departement of Oncology, UNIL-CHUV, University of Lausanne, Epalinges, Switzerland.ORCID http://orcid.org/0000-0001-8648-1324
Michel Akselrod *MySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.
Julia FellrathMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.
Giulia VanoniDepartement of Oncology, UNIL-CHUV, University of Lausanne, Epalinges, Switzerland.
Tommaso BertoniMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.ORCID http://orcid.org/0000-0002-4798-7733
Silvia SerinoMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.ORCID http://orcid.org/0000-0002-8422-1358
Georgia PapadopoulouTargeting of Cytokine Secreting Lymphocytes (TCSL) Laboratory, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0003-2025-3657
Maren BornMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.
Matteo GirondiniMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.ORCID http://orcid.org/0000-0003-4156-0779
Giuseppe ErcolanoDepartement of Oncology, UNIL-CHUV, University of Lausanne, Epalinges, Switzerland.ORCID http://orcid.org/0000-0001-6026-2588
Giulia EllenaMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.
Anthony CornuDepartement of Oncology, UNIL-CHUV, University of Lausanne, Epalinges, Switzerland.
Giulio MastriaMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.ORCID http://orcid.org/0000-0003-2900-1480
Hector Gallart-AyalaMetabolomics and Lipidomics Platform, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-2333-0646
Julijana IvanisevicMetabolomics and Lipidomics Platform, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-8267-2705
Petr GrivazMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland.
Maria Paola PaladinoDepartment of Psychology and Cognitive Science, University of Trento, Trento, Italy.
Camilla JandusDepartement of Oncology, UNIL-CHUV, University of Lausanne, Epalinges, Switzerland. camilla.jandus@unige.ch.ORCID http://orcid.org/0000-0002-7405-5747
Andrea SerinoMySpace Lab and NeuroRehab Research Center, Service of University Neurorehabilitation (SUN), Lausanne University Hospital, Institution of Lavigny and University of Lausanne, Switzerland, Switzerland. andrea.serino@unil.ch.ORCID http://orcid.org/0000-0001-7475-6095

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRSII5_209416Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRSK-3_190883 / 1Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) PP00P3_163951Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) PR00P3_179727Université de Lausanne (University of Lausanne) FUNILUniversité de Lausanne (University of Lausanne) Interdisciplinary grant from Faculty of Biology and MedicineUniversité de Lausanne (University of Lausanne) Interdisciplinary grant from the Faculty of Biology and Medicine
6 · The paper itself

Abstract

Once contact with a pathogen has occurred, it might be too late for the immune system to react. Here, we asked whether anticipatory neural responses might sense potential infections and signal to the immune system, priming it for a response. We show that potential contact with approaching infectious avatars, entering the peripersonal space in virtual reality, are anticipated by multisensory-motor areas and activate the salience network, as measured with psychophysics, electroencephalography and functional magnetic resonance imaging. This proactive neural anticipation instigates changes in both the frequency and activation of innate lymphoid cells, mirroring responses seen in actual infections. Alterations in connectivity patterns between infection-sensing brain regions and the hypothalamus, along with modulation of neural mediators, connect these effects to the hypothalamic-pituitary-adrenal axis. Neural network modeling recapitulates this neuro-immune cross-talk. These findings suggest an integrated neuro-immune reaction in humans toward infection threats, not solely following physical contact but already after breaching the functional boundary of body-environment interaction represented by the peripersonal space.

Indexed as

Anticipation, PsychologicalBrainInfectionsVirtual RealityAdultElectroencephalographyFemaleHumansMagnetic Resonance ImagingMaleYoung Adult

Identifiers

PMID40721674
PMCPMC12411218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.